| Clinical significance of androgen receptor splice variant-7 mRNA detection in circulating tumor cells of men with metastatic castration-resistant prostate cancer treated with … ES Antonarakis, C Lu, B Luber, H Wang, Y Chen, Y Zhu, JL Silberstein, ... Journal of Clinical Oncology 35 (19), 2149-2156, 2017 | 478 | 2017 |
| Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer C Liu, W Lou, Y Zhu, N Nadiminty, CT Schwartz, CP Evans, AC Gao Clinical cancer research 20 (12), 3198-3210, 2014 | 372 | 2014 |
| Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer C Liu, W Lou, Y Zhu, JC Yang, N Nadiminty, NW Gaikwad, CP Evans, ... Cancer research 75 (7), 1413-1422, 2015 | 270 | 2015 |
| MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells N Nadiminty, R Tummala, W Lou, Y Zhu, J Zhang, X Chen, RWV White, ... Journal of Biological Chemistry 287 (2), 1527-1537, 2012 | 218 | 2012 |
| MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth N Nadiminty, R Tummala, W Lou, Y Zhu, XB Shi, JX Zou, H Chen, J Zhang, ... PloS one 7 (3), e32832, 2012 | 207 | 2012 |
| Functional p53 determines docetaxel sensitivity in prostate cancer cells C Liu, Y Zhu, W Lou, N Nadiminty, X Chen, Q Zhou, XB Shi, ... The Prostate 73 (4), 418-427, 2013 | 152 | 2013 |
| Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer Y Zhu, C Liu, N Nadiminty, W Lou, R Tummala, CP Evans, AC Gao Molecular cancer therapeutics 12 (9), 1829-1836, 2013 | 138 | 2013 |
| Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3‐AR axis inhibition C Liu, W Lou, C Armstrong, Y Zhu, CP Evans, AC Gao The Prostate 75 (13), 1341-1353, 2015 | 116 | 2015 |
| Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells C Liu, Y Zhu, W Lou, Y Cui, CP Evans, AC Gao The Prostate 74 (2), 201-209, 2014 | 116 | 2014 |
| Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer C Liu, C Armstrong, Y Zhu, W Lou, AC Gao Oncotarget 7 (22), 32210, 2016 | 109 | 2016 |
| Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion M Sun, C Liu, N Nadiminty, W Lou, Y Zhu, J Yang, CP Evans, Q Zhou, ... The Prostate 72 (1), 82-89, 2012 | 101 | 2012 |
| Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors Y Zhu, SL Dalrymple, I Coleman, SL Zheng, J Xu, JE Hooper, ... Oncogene 39 (45), 6935-6949, 2020 | 95 | 2020 |
| Interleukin‐6 induces neuroendocrine differentiation (NED) through suppression of RE‐1 silencing transcription factor (REST) Y Zhu, C Liu, Y Cui, N Nadiminty, W Lou, AC Gao The Prostate 74 (11), 1086-1094, 2014 | 82 | 2014 |
| Novel junction-specific and quantifiable in situ detection of AR-V7 and its clinical correlates in metastatic castration-resistant prostate cancer Y Zhu, A Sharp, CM Anderson, JL Silberstein, M Taylor, C Lu, P Zhao, ... European urology 73 (5), 727-735, 2018 | 69 | 2018 |
| Antiandrogens inhibit ABCB1 efflux and ATPase activity and reverse docetaxel resistance in advanced prostate cancer Y Zhu, C Liu, C Armstrong, W Lou, A Sandher, AC Gao Clinical Cancer Research 21 (18), 4133-4142, 2015 | 68 | 2015 |
| The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer K Wang, J Luo, S Yeh, B You, J Meng, P Chang, Y Niu, G Li, C Lu, Y Zhu, ... Nature communications 11 (1), 2689, 2020 | 59 | 2020 |
| Analytical validation of androgen receptor splice variant 7 detection in a clinical laboratory improvement amendments (CLIA) laboratory setting PM Lokhandwala, SL Riel, L Haley, C Lu, Y Chen, J Silberstein, Y Zhu, ... The Journal of Molecular Diagnostics 19 (1), 115-125, 2017 | 52 | 2017 |
| Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer C Liu, N Nadiminty, R Tummala, JY Chun, W Lou, Y Zhu, M Sun, ... Genes & cancer 2 (2), 151-159, 2011 | 49 | 2011 |
| Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer WN Brennen, Y Zhu, IM Coleman, SL Dalrymple, L Antony, RA Patel, ... JCI insight 6 (8), 2021 | 47 | 2021 |
| Lin28 promotes growth of prostate cancer cells and activates the androgen receptor R Tummala, N Nadiminty, W Lou, Y Zhu, R Gandour-Edwards, HW Chen, ... The American journal of pathology 183 (1), 288-295, 2013 | 41 | 2013 |
Allen C GaoUniversity of Califormia Davis確認したメール アドレス: ucdavis.edu